Human MAIT cells show metabolic quiescence with rapid glucose-dependent upregulation of granzyme B upon stimulation
Standard
Human MAIT cells show metabolic quiescence with rapid glucose-dependent upregulation of granzyme B upon stimulation. / Zinser, Madeleine E; Highton, Andrew J; Kurioka, Ayako; Kronsteiner, Barbara; Hagel, Joachim; Leng, Tianqi; Marchi, Emanuele; Phetsouphanh, Chansavath; Willberg, Chris B; Dunachie, Susanna J; Klenerman, Paul.
in: IMMUNOL CELL BIOL, Jahrgang 96, Nr. 6, 07.2018, S. 666-674.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Human MAIT cells show metabolic quiescence with rapid glucose-dependent upregulation of granzyme B upon stimulation
AU - Zinser, Madeleine E
AU - Highton, Andrew J
AU - Kurioka, Ayako
AU - Kronsteiner, Barbara
AU - Hagel, Joachim
AU - Leng, Tianqi
AU - Marchi, Emanuele
AU - Phetsouphanh, Chansavath
AU - Willberg, Chris B
AU - Dunachie, Susanna J
AU - Klenerman, Paul
N1 - This article is protected by copyright. All rights reserved.
PY - 2018/7
Y1 - 2018/7
N2 - Mucosal-associated invariant T (MAIT) cells are a well-characterized innate-like T cell population abundant in the human liver, peripheral tissues and blood. MAIT cells serve in the first line of defense against infections, through engagement of their T cell receptor, which recognizes microbial metabolites presented on MR1, and through cytokine-mediated triggering. Typically, they show a quiescent memory phenotype but can undergo rapid upregulation of effector functions including cytolysis upon stimulation. T cells profoundly change their cellular metabolism during their maturation and activation. We sought to determine how MAIT cell metabolism may facilitate both the long-term memory phase in tissue and the transition to rapid effector function. Here, we show, by flow cytometric metabolism assays and extracellular flux analysis that, despite an effector-memory profile, human MAIT cells are metabolically quiescent in a resting state comparable to naïve and central memory T cells. Upon stimulation, they rapidly increase uptake of glucose and show a concomitant upregulation of the effector molecules notably granzyme B, which is impaired by inhibition of glycolysis with 2-deoxyglucose. These findings suggest that MAIT cells share some metabolic characteristics of both resting and effector T cell subsets, with a rapid transition upon triggering. Metabolic programming of this cell type may be of interest in understanding and modulating their function in infectious diseases and cancer.
AB - Mucosal-associated invariant T (MAIT) cells are a well-characterized innate-like T cell population abundant in the human liver, peripheral tissues and blood. MAIT cells serve in the first line of defense against infections, through engagement of their T cell receptor, which recognizes microbial metabolites presented on MR1, and through cytokine-mediated triggering. Typically, they show a quiescent memory phenotype but can undergo rapid upregulation of effector functions including cytolysis upon stimulation. T cells profoundly change their cellular metabolism during their maturation and activation. We sought to determine how MAIT cell metabolism may facilitate both the long-term memory phase in tissue and the transition to rapid effector function. Here, we show, by flow cytometric metabolism assays and extracellular flux analysis that, despite an effector-memory profile, human MAIT cells are metabolically quiescent in a resting state comparable to naïve and central memory T cells. Upon stimulation, they rapidly increase uptake of glucose and show a concomitant upregulation of the effector molecules notably granzyme B, which is impaired by inhibition of glycolysis with 2-deoxyglucose. These findings suggest that MAIT cells share some metabolic characteristics of both resting and effector T cell subsets, with a rapid transition upon triggering. Metabolic programming of this cell type may be of interest in understanding and modulating their function in infectious diseases and cancer.
KW - Journal Article
U2 - 10.1111/imcb.12020
DO - 10.1111/imcb.12020
M3 - SCORING: Journal article
C2 - 29423939
VL - 96
SP - 666
EP - 674
JO - IMMUNOL CELL BIOL
JF - IMMUNOL CELL BIOL
SN - 0818-9641
IS - 6
ER -